Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Bioengineered|June 6, 2014
Bioengineered heparin: is there a future for this form of the successful therapeutic?Megan S Lord, John M WhitelockThe FEBS Journal|February 20, 2013
Recombinant production of proteoglycans and their bioactive domainsMegan S Lord, John M WhitelockBiochemistry|October 2, 2008
Diverse cell signaling events modulated by perlecanJohn M Whitelock, James Melrose, Renato V IozzoBioengineered|April 11, 2017
Optimization of bioengineered heparin/heparan sulfate production for therapeutic applicationsMegan S Lord, MoonSun Jung, John M WhitelockBiomaterials|May 12, 2012
Enzymatic degradation of heparin-modified hydrogels and its effect on bioactivityAnastasia Nilasaroya, Penny J Martens, John M WhitelockMatrix Biology : Journal of the International Society for Matrix Biology|April 22, 2009
Proteomics makes progress in cartilage and arthritis researchRichard Wilson, John M Whitelock, John F BatemanMethods in Molecular Biology (Clifton, N.J.)|October 19, 2014
Glycosaminoglycan functionalized nanoparticles exploit glycosaminoglycan functionsJames A Vassie, John M Whitelock, Megan S LordActa Biomaterialia|December 13, 2016
Endocytosis of cerium oxide nanoparticles and modulation of reactive oxygen species in human ovarian and colon cancer cellsJames A Vassie, John M Whitelock, Megan S LordMolecules (Basel, Switzerland)|May 16, 2017
Structure-Activity Relationships of Bioengineered Heparin/Heparan Sulfates Produced in Different BioreactorsHa Na Kim, John M Whitelock, Megan S LordMatrix Biology : Journal of the International Society for Matrix Biology|May 9, 2009
Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axisJason J Zoeller, John M Whitelock, Renato V IozzoPageof 9